ebomi
Colour theme
Sign in
Insider · CIK 0001259870

Biotech Target N V

CIK 0001259870 Name as filed on the most recent filing

Filed as Biotech Target N V (66)

86 transaction lines · from 66 filings · filed 2017-11-16 to 2024-11-18 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-11-14 S, Open-market sale Molecular Templates, Inc.MTEM 845,833, disposed Open Form 4 filing 0000950170-24-128208
2024-04-02 P, Open-market purchase Molecular Templates, Inc.MTEM 587,500, acquired Open Form 4 filing 0000950170-24-042010
2023-10-02 P, Open-market purchase MacRogenics IncMGNX 669,585, acquired Open Form 4 filing 0000899243-23-019881
2023-09-07 P, Open-market purchase MacRogenics IncMGNX 1,052,840, acquired Open Form 4 filing 0000899243-23-018688
2023-07-17 P, Open-market purchase Molecular Templates, Inc.MTEM 2,000,000, acquired Open Form 4 filing 0000950170-23-033494
2023-02-14 P, Open-market purchase MacRogenics IncMGNX 2,532,600, acquired Open Form 4 filing 0000899243-23-005209
2023-01-19 P, Open-market purchase MacRogenics IncMGNX 794,925, acquired Open Form 4 filing 0000899243-23-002378
2022-12-27 P, Open-market purchase MacRogenics IncMGNX 1,121,800, acquired Open Form 4 filing 0000899243-22-039423
2022-12-23 P, Open-market purchase MacRogenics IncMGNX 1,176,800, acquired Open Form 4 filing 0000899243-22-039423
2022-11-22 P, Open-market purchase MacRogenics IncMGNX 1,788,180, acquired Open Form 4 filing 0000899243-22-036996
2022-10-24 P, Open-market purchase MacRogenics IncMGNX 1,090,500, acquired Open Form 4 filing 0000899243-22-034118
2022-10-21 P, Open-market purchase MacRogenics IncMGNX 1,157,100, acquired Open Form 4 filing 0000899243-22-034118
2022-10-20 P, Open-market purchase MacRogenics IncMGNX 1,143,565, acquired Open Form 4 filing 0000899243-22-033943
2022-10-19 P, Open-market purchase MacRogenics IncMGNX 623,919, acquired Open Form 4 filing 0000899243-22-033943
2022-05-18 P, Open-market purchase Radius Health, Inc.RDUS 2,661,002, acquired Open Form 4 filing 0000899243-22-018984
2022-05-16 P, Open-market purchase Molecular Templates, Inc.MTEM 236,200, acquired Open Form 4 filing 0000899243-22-018544
2022-01-06 P, Open-market purchase Radius Health, Inc.RDUS 1,894,410, acquired Open Form 4 filing 0000899243-22-001316
2022-01-06 P, Open-market purchase Molecular Templates, Inc.MTEM 807,180, acquired Open Form 4 filing 0000899243-22-001433
2022-01-05 P, Open-market purchase Radius Health, Inc.RDUS 1,574,650, acquired Open Form 4 filing 0000899243-22-001316
2021-11-19 P, Open-market purchase MacRogenics IncMGNX 3,700,320, acquired Open Form 4 filing 0000899243-21-045703
2021-09-29 P, Open-market purchase Radius Health, Inc.RDUS 1,294,500, acquired Open Form 4 filing 0000899243-21-038590
2021-09-29 P, Open-market purchase MacRogenics IncMGNX 2,047,460, acquired Open Form 4 filing 0000899243-21-038368
2021-09-28 P, Open-market purchase MacRogenics IncMGNX 2,063,960, acquired Open Form 4 filing 0000899243-21-038368
2021-09-22 P, Open-market purchase Radius Health, Inc.RDUS 1,841,280, acquired Open Form 4 filing 0000899243-21-037557
2021-09-21 P, Open-market purchase Molecular Templates, Inc.MTEM 4,500,000, acquired Open Form 4 filing 0000899243-21-037292
2021-09-17 P, Open-market purchase MacRogenics IncMGNX 3,986,680, acquired Open Form 4 filing 0000899243-21-036543
2021-09-16 P, Open-market purchase MacRogenics IncMGNX 8,376,800, acquired Open Form 4 filing 0000899243-21-036543
2021-09-16 P, Open-market purchase Molecular Templates, Inc.MTEM 613,000, acquired Open Form 4 filing 0000899243-21-036541
2021-07-27 P, Open-market purchase Molecular Templates, Inc.MTEM 531,840, acquired Open Form 4 filing 0000899243-21-030317
2021-07-26 P, Open-market purchase Molecular Templates, Inc.MTEM 559,816, acquired Open Form 4 filing 0000899243-21-030317
2021-07-20 P, Open-market purchase Molecular Templates, Inc.MTEM 891,675, acquired Open Form 4 filing 0000899243-21-029181
2021-07-19 P, Open-market purchase Molecular Templates, Inc.MTEM 830,827, acquired Open Form 4 filing 0000899243-21-029181
2021-06-21 P, Open-market purchase MacRogenics IncMGNX 1,630,170, acquired Open Form 4 filing 0000899243-21-025485
2021-06-16 P, Open-market purchase MacRogenics IncMGNX 2,104,390, acquired Open Form 4 filing 0000899243-21-024412
2021-06-15 P, Open-market purchase MacRogenics IncMGNX 1,539,615, acquired Open Form 4 filing 0000899243-21-024412
2021-05-24 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 2,021,620, acquired Open Form 4 filing 0000899243-21-020706
2021-05-19 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 4,073,960, acquired Open Form 4 filing 0000899243-21-020330
2021-05-06 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 1,645,632, acquired Open Form 4 filing 0000899243-21-018635
2021-05-05 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 3,002,850, acquired Open Form 4 filing 0000899243-21-018635
2021-04-19 P, Open-market purchase Molecular Templates, Inc.MTEM 329,941, acquired Open Form 4 filing 0000899243-21-016530
2021-04-15 P, Open-market purchase Molecular Templates, Inc.MTEM 1,292,655, acquired Open Form 4 filing 0000899243-21-016175
2021-04-14 P, Open-market purchase Molecular Templates, Inc.MTEM 1,256,040, acquired Open Form 4 filing 0000899243-21-015925
2021-04-13 P, Open-market purchase Molecular Templates, Inc.MTEM 780,970, acquired Open Form 4 filing 0000899243-21-015925
2021-04-12 P, Open-market purchase Molecular Templates, Inc.MTEM 400,830, acquired Open Form 4 filing 0000899243-21-015608
2021-04-09 P, Open-market purchase Molecular Templates, Inc.MTEM 1,939,633, acquired Open Form 4 filing 0000899243-21-015608
2021-04-08 P, Open-market purchase Molecular Templates, Inc.MTEM 2,466,660, acquired Open Form 4 filing 0000899243-21-015470
2021-04-07 P, Open-market purchase Molecular Templates, Inc.MTEM 1,648,160, acquired Open Form 4 filing 0000899243-21-015470
2021-04-05 P, Open-market purchase Molecular Templates, Inc.MTEM 1,887,100, acquired Open Form 4 filing 0000899243-21-015196
2021-03-29 P, Open-market purchase Molecular Templates, Inc.MTEM 915,848, acquired Open Form 4 filing 0000899243-21-014121
2021-02-24 P, Open-market purchase Molecular Templates, Inc.MTEM 860,835, acquired Open Form 4 filing 0000899243-21-008183

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. BIOTECH TARGET N V, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001259870

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.